Skip to main content
. 2018 Oct 16;84(4):527–536. doi: 10.1002/ana.25313

Figure 1.

Figure 1

Clinical and subclinical components of NEPAD. No Evidence of Progression defined as: no 12‐week CDP, as measured by the EDSS; no evidence of 12‐week confirmed ≥ 20% progression on hand/arm function as measured by 9HPT; no evidence of 12‐week confirmed ≥ 20% progression on ambulation as measured by the T25FW test. 9HPT = 9‐Hole Peg Test; CDP = confirmed disability progression; EDSS = Expanded Disability Status Scale; Gd+ = gadolinium‐enhancing; MRI = magnetic resonance imaging; NEPAD = no evidence of progression or active disease; T25FW = Timed 25‐Foot Walk.